Search by Drug Name or NDC

    NDC 00074-4382-20 Nimbex 10 mg/mL Details

    Nimbex 10 mg/mL

    Nimbex is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AbbVie Inc.. The primary component is CISATRACURIUM BESYLATE.

    Product Information

    NDC 00074-4382
    Product ID 0074-4382_8b56347b-c00b-40d9-a41a-c926e4b1c357
    Associated GPIs 74200013102035
    GCN Sequence Number 024613
    GCN Sequence Number Description cisatracurium besylate VIAL 10 MG/ML INTRAVEN
    HIC3 S7A
    HIC3 Description NEUROMUSCULAR BLOCKING AGENTS
    GCN 32770
    HICL Sequence Number 010278
    HICL Sequence Number Description CISATRACURIUM BESYLATE
    Brand/Generic Brand
    Proprietary Name Nimbex
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cisatracurium besylate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 10
    Active Ingredient Units mg/mL
    Substance Name CISATRACURIUM BESYLATE
    Labeler Name AbbVie Inc.
    Pharmaceutical Class Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020551
    Listing Certified Through 2023-12-31

    Package

    NDC 00074-4382-20 (00074438220)

    NDC Package Code 0074-4382-20
    Billing NDC 00074438220
    Package 20 mL in 1 VIAL, SINGLE-DOSE (0074-4382-20)
    Marketing Start Date 1995-12-15
    NDC Exclude Flag N
    Pricing Information N/A